Alison Drinkwater

Governments, players and healthcare’s other stakeholders are increasingly required to incorporate quality data to support their submissions for reimbursement.  Explore new approaches to using Real World Evidence to improve the value proposition your medicines bring to the decision process and to patients. Take away strategies to:

• Enhance the efficacy of your medications on individual patient outcomes
• Evaluate the impact on the health of the overall patient population for your medication
• Partner with your stakeholders to access data

Prove and improve the value, efficacy and impact of your medications with RWE

Continued tightening of access to private payor formularies combined with a move to outsource benefit plan and administration to third parties for some payers, means more barriers to access this market than before.  Hone your private payor access strategy by understanding new market developments and payor priorities.  Create an action plan to:

• Leverage elements of successful public PLA submissions and adapt them for the private payer market
• Analyze the influence of public payer decisions on private payors to increase your preparedness
• What pharma companies can do to optimize the ROI of their submissions to private payers

Gain insight into what private payers need and succeed with a tailored approach to securing a PLA